The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.

The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.

The 2016 NCCN Case Manager and Medical Director Program Live Webinar Series will consist of six webinars on the topics of colorectal cancer, prostate cancer, distress management, CML, ovarian cancer, and multiple myeloma.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Join Katalin Kelemen, MD, PhD and Ruben A. Mesa, MD from Mayo Clinic Cancer Center as they present their expertise on a range of cases pertaining to myeloproliferative neoplasms, with a specific focus on myelofibrosis.

Join Prashant Kapoor, MD and Shaji Kumar, MD from Mayo Clinic Cancer Center as they present their expertise on a range of cases pertaining to multiple myeloma.

Join Gregory Daniels, MD, PhD and Brian Hinds, MD from the University of California, San Diego as they present their expertise on a range of cases pertaining to melanoma.